05.24.23
The US Environmental Protection Agency (EPA) approved EvaClean’s PurOne Cleaner and Disinfectant’s updated master label with a C. auris claim. The cleaner and disinfectant is now one of the only products on the market that is effective against both biofilm and C auris, according to EvaClean Infection Prevention Solutions.
In the last several months, concerns over a dramatic increase in Candida auris (C. auris) infections have arisen in healthcare facilities. An even greater concern is this fungus can form biofilms, which allow it to persist in the environment and be more resistant to common disinfectants, said EvaClean.
EvaClean Infection Prevention Solution’s PurOne was the first disinfectant to be US EPA registered against dry surface biofilm; only a handful of products can claim to date, according to the Braintree, MA-based company.
The EPA approval of its updated master label to include a soft surface sanitizer claim, shorter dwell times, and an official C. auris claim, makes PurOne among the few products registered as effective against both biofilm and C auris on List P.
"The new label further substantiates how advanced our chemistry is," said EvaClean CEO Steve Wilson. "More importantly, PurOne provides a platform for educating healthcare professionals on the necessity for addressing surface biofilm to truly eradicate pathogenic threats."
Another important upgrade to the label, according to EvaClean, is considerably faster contact times for more than 40 different bacteria, viruses, and fungi, most achieved at lower concentrations. For instance, influenza can be eliminated in just two minutes using 1076 parts per million (ppm) dilution. In addition, PurOne now has an enhanced emerging viral pathogen claim, having proven effective against small non-enveloped pathogens at a lower 2153 ppm concentration, said the company.
Though PurOne is a healthcare-grade disinfectant that penetrates biofilm and is effective against bloodborne viruses, Gram-positive and Gram-negative bacteria, it is also meets the Center for Disease Control and Prevention’s (CDC) 13 properties of an ideal disinfectant: broad spectrum antimicrobial efficacy; fast acting; not affected by environmental factors; nontoxic to users and patients; surface compatibility; residual effect; easy to use; pleasant odor; economical; soluble; stable; good cleaning properties; and environmentally friendly.
"PurOne does it all. Lower concentrations and speed of efficacy give hospitals the ability to use one product to clean, deodorize, remove stains, and disinfect facility-wide, from floors to toilet bowls and most everywhere in between, thereby simplifying and improving processes,” said Kurt Wong, COO.
In the last several months, concerns over a dramatic increase in Candida auris (C. auris) infections have arisen in healthcare facilities. An even greater concern is this fungus can form biofilms, which allow it to persist in the environment and be more resistant to common disinfectants, said EvaClean.
EvaClean Infection Prevention Solution’s PurOne was the first disinfectant to be US EPA registered against dry surface biofilm; only a handful of products can claim to date, according to the Braintree, MA-based company.
The EPA approval of its updated master label to include a soft surface sanitizer claim, shorter dwell times, and an official C. auris claim, makes PurOne among the few products registered as effective against both biofilm and C auris on List P.
"The new label further substantiates how advanced our chemistry is," said EvaClean CEO Steve Wilson. "More importantly, PurOne provides a platform for educating healthcare professionals on the necessity for addressing surface biofilm to truly eradicate pathogenic threats."
Another important upgrade to the label, according to EvaClean, is considerably faster contact times for more than 40 different bacteria, viruses, and fungi, most achieved at lower concentrations. For instance, influenza can be eliminated in just two minutes using 1076 parts per million (ppm) dilution. In addition, PurOne now has an enhanced emerging viral pathogen claim, having proven effective against small non-enveloped pathogens at a lower 2153 ppm concentration, said the company.
Though PurOne is a healthcare-grade disinfectant that penetrates biofilm and is effective against bloodborne viruses, Gram-positive and Gram-negative bacteria, it is also meets the Center for Disease Control and Prevention’s (CDC) 13 properties of an ideal disinfectant: broad spectrum antimicrobial efficacy; fast acting; not affected by environmental factors; nontoxic to users and patients; surface compatibility; residual effect; easy to use; pleasant odor; economical; soluble; stable; good cleaning properties; and environmentally friendly.
"PurOne does it all. Lower concentrations and speed of efficacy give hospitals the ability to use one product to clean, deodorize, remove stains, and disinfect facility-wide, from floors to toilet bowls and most everywhere in between, thereby simplifying and improving processes,” said Kurt Wong, COO.